OROPHARYNGEAL EXCRETION OF EPSTEIN-BARR VIRUS BY RENAL TRANSPLANT RECIPIENTS AND OTHER PATIENTS TREATED WITH IMMUNOSUPPRESSIVE DRUGS
- 1 February 1974
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 303 (7851), 234-237
- https://doi.org/10.1016/s0140-6736(74)92546-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Pilot experiments with EB virus in owl monkeys (aotus trivirgatus). I. Reticuloproliferative disease in an inoculated animalInternational Journal of Cancer, 1973
- Malignant Lymphoma in Cottontop Marmosets after Inoculation with Epstein-Barr VirusProceedings of the National Academy of Sciences, 1973
- RISK OF CANCER IN RENAL-TRANSPLANT RECIPIENTSThe Lancet, 1973
- Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell linesInternational Journal of Cancer, 1973
- Prolonged Oropharyngeal Excretion of Epstein–Barr Virus after Infectious MononucleosisNew England Journal of Medicine, 1973
- ORAL EXCRETION OF EPSTEIN-BARR VIRUS BY HEALTHY SUBJECTS AND PATIENTS WITH INFECTIOUS MONONUCLEOSISThe Lancet, 1972
- EVIDENCE FOR ORAL EXCRETION OF E.B. VIRUS IN INFECTIOUS MONONUCLEOSISThe Lancet, 1972
- Transformation of Human Leucocytes by Throat Washing from Infectious Mononucleosis PatientsNature, 1971
- HERPES-SIMPLEX-VIRUS INFECTION AFTER RENAL TRANSPLANTATIONThe Lancet, 1969
- Cytomegalovirus infection after renal allotransplantationPublished by American Medical Association (AMA) ,1967